News

Releases

22. December, 2023

Positive topline data from study 0205 with its lead candidate CT001 for the treatment of pain in children supporting further advancement of CT001

The study a double-blinded, randomised, placebo-controlled in adults demonstrated that CT001 was superior to...

Read more

Releases

21. September, 2023

Cessatech announces last participant dosed in pivotal trial 0205 with lead candidate CT001

Last participant has been randomised in clinical trial 0205 investigating efficacy and safety of...

Read more

Releases

12. September, 2023

Cessatech announces agreement with the European Medicines Agency on a Paediatric Investigational Plan for its second asset CT002 for medical procedural sedation in children

On 12 September – Cessatech A/S (“Cessatech” or “the Company”) announces that EMA’s Paediatric...

Read more

Releases

31. August, 2023

August business update

  A short update to the great progress we continue to make….thanks for reading!...

Read more

Facts

25. August, 2023

New findings supporting CT001

Based on new findings in a 2023 meta-analysis by Fjendbo Galili et al., which...

Read more

Releases

24. August, 2023

Second quarter report Q2-2023

US co-development and commercialization partnership signed for CT001 – potential income already from 2024...

Read more

Releases

27. June, 2023

Cessatech and Ventis Pharma announce US partnership for CT001

On 27 June – Cessatech A/S (“Cessatech” or “the Company”) announces that the Company...

Read more

Releases

12. May, 2023

First quarter report Q1-2023 with Q&A

First quarter report Q1-2023 Study 0205 is progressing, with last patient expected in Q3...

Read more

Releases

23. March, 2023

Cessatech announces new Chairman of the Board

On 23 March 2023 Cessatech A/S announces that the Board of Directors has appointed...

Read more

Releases

28. February, 2023

Annual Report for the fiscal year 2022

Cessatech today publishes its annual report for the fiscal year 2022, which also includes...

Read more

Media

11. February, 2023

Massive presence of off-label medicines in Danish neonatal departments

A nationwide survey using national hospital purchase data. Overall, off-label medication was widespread covering...

Read more

Stay up to date!

Subscribe and get notified on Cessatech's latest news.
An acceptance email will be sent to you, please check your spam.